| scholarly article | Q13442814 |
| P356 | DOI | 10.1093/INFDIS/160.6.929 |
| P698 | PubMed publication ID | 2555420 |
| P2093 | author name string | Harris JP | |
| Richman DD | |||
| Koehrn FJ | |||
| Woolf NK | |||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Cytomegalovirus | Q6946 |
| sensorineural hearing loss | Q928697 | ||
| maternal health | Q6786626 | ||
| hearing loss | Q16035842 | ||
| P304 | page(s) | 929-937 | |
| P577 | publication date | 1989-12-01 | |
| P1433 | published in | Journal of Infectious Diseases | Q4051141 |
| P1476 | title | Congenital cytomegalovirus labyrinthitis and sensorineural hearing loss in guinea pigs. | |
| P478 | volume | 160 |
| Q91675842 | A fifty-year odyssey: prospects for a cytomegalovirus vaccine in transplant and congenital infection |
| Q36502807 | Altered development of the brain after focal herpesvirus infection of the central nervous system. |
| Q90062915 | Animal Models of Congenital Cytomegalovirus Transmission: Implications for Vaccine Development |
| Q33287117 | Congenital lymphocytic choriomeningitis virus infection: spectrum of disease |
| Q27000998 | Cytomegalovirus antivirals and development of improved animal models |
| Q34549638 | Cytomegalovirus blood viral load and hearing loss in young children with congenital infection |
| Q37377204 | Cytomegalovirus shedding and delayed sensorineural hearing loss: results from longitudinal follow-up of children with congenital infection |
| Q37574334 | Developing a Vaccine against Congenital Cytomegalovirus (CMV) Infection: What Have We Learned from Animal Models? Where Should We Go Next? |
| Q50084100 | Do viruses cause inner ear disturbances? |
| Q42262590 | Effects of immunization of pregnant guinea pigs with guinea pig cytomegalovirus glycoprotein B on viral spread in the placenta |
| Q36517126 | Guinea Pig Cytomegalovirus (GPCMV): A Model for the Study of the Prevention and Treatment of Maternal-Fetal Transmission |
| Q30430796 | Immune system of the inner ear as a novel therapeutic target for sensorineural hearing loss |
| Q37829983 | Implementing neonatal screening for congenital cytomegalovirus: addressing the deafness of policy makers. |
| Q46445885 | Macrophage inflammatory proteins in cytomegalovirus-related inner ear injury |
| Q38257810 | Models of vertical cytomegalovirus (CMV) transmission and pathogenesis |
| Q27320589 | Murine CMV-induced hearing loss is associated with inner ear inflammation and loss of spiral ganglia neurons |
| Q34607974 | Murine model for congenital CMV infection and hearing impairment |
| Q89489115 | Neutralizing antibodies to gB based CMV vaccine requires full length antigen but reduced virus neutralization on non-fibroblast cells limits vaccine efficacy in the guinea pig model |
| Q36359756 | Nonprimate models of congenital cytomegalovirus (CMV) infection: gaining insight into pathogenesis and prevention of disease in newborns |
| Q34434818 | Progress toward an elusive goal: current status of cytomegalovirus vaccines |
| Q35719997 | Transplacental murine cytomegalovirus infection in the brain of SCID mice |
Search more.